nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP1A2—Estropipate—osteoporosis	0.0884	0.121	CbGbCtD
Praziquantel—CYP3A7—Estradiol—osteoporosis	0.0658	0.0901	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0658	0.0901	CbGbCtD
Praziquantel—CYP2C19—Cholecalciferol—osteoporosis	0.0494	0.0676	CbGbCtD
Praziquantel—CYP3A5—Estradiol—osteoporosis	0.0493	0.0676	CbGbCtD
Praziquantel—CYP3A4—Estropipate—osteoporosis	0.0463	0.0635	CbGbCtD
Praziquantel—CYP3A4—Calcitriol—osteoporosis	0.0463	0.0635	CbGbCtD
Praziquantel—CYP1A2—Conjugated Estrogens—osteoporosis	0.0418	0.0573	CbGbCtD
Praziquantel—CYP2C19—Estradiol—osteoporosis	0.0398	0.0545	CbGbCtD
Praziquantel—CYP2D6—Cholecalciferol—osteoporosis	0.0375	0.0514	CbGbCtD
Praziquantel—CYP3A4—Ergocalciferol—osteoporosis	0.037	0.0507	CbGbCtD
Praziquantel—CYP1A2—Estradiol—osteoporosis	0.0367	0.0503	CbGbCtD
Praziquantel—CYP3A4—Raloxifene—osteoporosis	0.0309	0.0423	CbGbCtD
Praziquantel—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0298	0.0409	CbGbCtD
Praziquantel—CYP3A4—Cholecalciferol—osteoporosis	0.0239	0.0327	CbGbCtD
Praziquantel—CYP3A4—Conjugated Estrogens—osteoporosis	0.0219	0.03	CbGbCtD
Praziquantel—CYP3A4—Estradiol—osteoporosis	0.0192	0.0264	CbGbCtD
Praziquantel—Malaise—Ethinyl Estradiol—osteoporosis	0.000898	0.00354	CcSEcCtD
Praziquantel—Anorexia—Calcitriol—osteoporosis	0.000897	0.00354	CcSEcCtD
Praziquantel—Abdominal discomfort—Estradiol—osteoporosis	0.000894	0.00352	CcSEcCtD
Praziquantel—Somnolence—Estropipate—osteoporosis	0.000891	0.00351	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000885	0.00349	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000876	0.00345	CcSEcCtD
Praziquantel—Immune system disorder—Zoledronate—osteoporosis	0.000875	0.00345	CcSEcCtD
Praziquantel—Vertigo—Risedronate—osteoporosis	0.000872	0.00344	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Estropipate—osteoporosis	0.000866	0.00341	CcSEcCtD
Praziquantel—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000865	0.00341	CcSEcCtD
Praziquantel—Arrhythmia—Zoledronate—osteoporosis	0.000865	0.00341	CcSEcCtD
Praziquantel—Fatigue—Estropipate—osteoporosis	0.000864	0.00341	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000857	0.00338	CcSEcCtD
Praziquantel—Ill-defined disorder—Pamidronate—osteoporosis	0.000856	0.00337	CcSEcCtD
Praziquantel—Hypersensitivity—Etidronic acid—osteoporosis	0.000854	0.00336	CcSEcCtD
Praziquantel—Immune system disorder—Conjugated Estrogens—osteoporosis	0.000842	0.00332	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000842	0.00332	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000838	0.0033	CcSEcCtD
Praziquantel—Discomfort—Ethinyl Estradiol—osteoporosis	0.000838	0.0033	CcSEcCtD
Praziquantel—Somnolence—Calcitriol—osteoporosis	0.000837	0.0033	CcSEcCtD
Praziquantel—Decreased appetite—Ibandronate—osteoporosis	0.000836	0.00329	CcSEcCtD
Praziquantel—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000833	0.00328	CcSEcCtD
Praziquantel—Malaise—Pamidronate—osteoporosis	0.000832	0.00328	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00083	0.00327	CcSEcCtD
Praziquantel—Fatigue—Ibandronate—osteoporosis	0.000829	0.00327	CcSEcCtD
Praziquantel—Myalgia—Risedronate—osteoporosis	0.000827	0.00326	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000821	0.00323	CcSEcCtD
Praziquantel—Pruritus—Etidronic acid—osteoporosis	0.00082	0.00323	CcSEcCtD
Praziquantel—Gastrointestinal pain—Estropipate—osteoporosis	0.00082	0.00323	CcSEcCtD
Praziquantel—Decreased appetite—Calcitriol—osteoporosis	0.000818	0.00322	CcSEcCtD
Praziquantel—Feeling abnormal—Alendronate—osteoporosis	0.000814	0.00321	CcSEcCtD
Praziquantel—Gastrointestinal pain—Alendronate—osteoporosis	0.000807	0.00318	CcSEcCtD
Praziquantel—Convulsion—Pamidronate—osteoporosis	0.0008	0.00315	CcSEcCtD
Praziquantel—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000797	0.00314	CcSEcCtD
Praziquantel—Urticaria—Estropipate—osteoporosis	0.000796	0.00314	CcSEcCtD
Praziquantel—Gastrointestinal pain—Raloxifene—osteoporosis	0.000794	0.00313	CcSEcCtD
Praziquantel—Diarrhoea—Etidronic acid—osteoporosis	0.000793	0.00312	CcSEcCtD
Praziquantel—Abdominal pain—Estropipate—osteoporosis	0.000793	0.00312	CcSEcCtD
Praziquantel—Body temperature increased—Estropipate—osteoporosis	0.000793	0.00312	CcSEcCtD
Praziquantel—Feeling abnormal—Ibandronate—osteoporosis	0.000792	0.00312	CcSEcCtD
Praziquantel—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000789	0.00311	CcSEcCtD
Praziquantel—Gastrointestinal pain—Ibandronate—osteoporosis	0.000786	0.0031	CcSEcCtD
Praziquantel—Myalgia—Pamidronate—osteoporosis	0.000786	0.0031	CcSEcCtD
Praziquantel—Urticaria—Alendronate—osteoporosis	0.000784	0.00309	CcSEcCtD
Praziquantel—Ill-defined disorder—Zoledronate—osteoporosis	0.000782	0.00308	CcSEcCtD
Praziquantel—Abdominal pain—Alendronate—osteoporosis	0.000781	0.00308	CcSEcCtD
Praziquantel—Body temperature increased—Alendronate—osteoporosis	0.000781	0.00308	CcSEcCtD
Praziquantel—Nervous system disorder—Risedronate—osteoporosis	0.000777	0.00306	CcSEcCtD
Praziquantel—Discomfort—Pamidronate—osteoporosis	0.000776	0.00306	CcSEcCtD
Praziquantel—Skin disorder—Risedronate—osteoporosis	0.00077	0.00303	CcSEcCtD
Praziquantel—Gastrointestinal pain—Calcitriol—osteoporosis	0.00077	0.00303	CcSEcCtD
Praziquantel—Abdominal pain—Raloxifene—osteoporosis	0.000768	0.00303	CcSEcCtD
Praziquantel—Body temperature increased—Raloxifene—osteoporosis	0.000768	0.00303	CcSEcCtD
Praziquantel—Urticaria—Ibandronate—osteoporosis	0.000764	0.00301	CcSEcCtD
Praziquantel—Malaise—Zoledronate—osteoporosis	0.00076	0.003	CcSEcCtD
Praziquantel—Body temperature increased—Ibandronate—osteoporosis	0.00076	0.00299	CcSEcCtD
Praziquantel—Abdominal pain—Ibandronate—osteoporosis	0.00076	0.00299	CcSEcCtD
Praziquantel—Vertigo—Zoledronate—osteoporosis	0.000757	0.00298	CcSEcCtD
Praziquantel—Urticaria—Calcitriol—osteoporosis	0.000748	0.00295	CcSEcCtD
Praziquantel—Body temperature increased—Calcitriol—osteoporosis	0.000744	0.00293	CcSEcCtD
Praziquantel—Abdominal pain—Calcitriol—osteoporosis	0.000744	0.00293	CcSEcCtD
Praziquantel—Hypersensitivity—Estropipate—osteoporosis	0.000739	0.00291	CcSEcCtD
Praziquantel—Nervous system disorder—Pamidronate—osteoporosis	0.000739	0.00291	CcSEcCtD
Praziquantel—Vomiting—Etidronic acid—osteoporosis	0.000737	0.0029	CcSEcCtD
Praziquantel—Rash—Etidronic acid—osteoporosis	0.000731	0.00288	CcSEcCtD
Praziquantel—Convulsion—Zoledronate—osteoporosis	0.00073	0.00288	CcSEcCtD
Praziquantel—Dermatitis—Etidronic acid—osteoporosis	0.00073	0.00288	CcSEcCtD
Praziquantel—Vertigo—Conjugated Estrogens—osteoporosis	0.000729	0.00287	CcSEcCtD
Praziquantel—Hypersensitivity—Alendronate—osteoporosis	0.000728	0.00287	CcSEcCtD
Praziquantel—Headache—Etidronic acid—osteoporosis	0.000726	0.00286	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000722	0.00284	CcSEcCtD
Praziquantel—Asthenia—Estropipate—osteoporosis	0.000719	0.00283	CcSEcCtD
Praziquantel—Anorexia—Pamidronate—osteoporosis	0.000718	0.00283	CcSEcCtD
Praziquantel—Myalgia—Zoledronate—osteoporosis	0.000718	0.00283	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000713	0.00281	CcSEcCtD
Praziquantel—Pruritus—Estropipate—osteoporosis	0.000709	0.0028	CcSEcCtD
Praziquantel—Discomfort—Zoledronate—osteoporosis	0.000709	0.00279	CcSEcCtD
Praziquantel—Asthenia—Alendronate—osteoporosis	0.000708	0.00279	CcSEcCtD
Praziquantel—Hypersensitivity—Ibandronate—osteoporosis	0.000708	0.00279	CcSEcCtD
Praziquantel—Convulsion—Conjugated Estrogens—osteoporosis	0.000703	0.00277	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000702	0.00276	CcSEcCtD
Praziquantel—Fatigue—Ethinyl Estradiol—osteoporosis	0.000701	0.00276	CcSEcCtD
Praziquantel—Pruritus—Alendronate—osteoporosis	0.000699	0.00275	CcSEcCtD
Praziquantel—Hypersensitivity—Calcitriol—osteoporosis	0.000693	0.00273	CcSEcCtD
Praziquantel—Cardiac disorder—Estradiol—osteoporosis	0.000693	0.00273	CcSEcCtD
Praziquantel—Myalgia—Conjugated Estrogens—osteoporosis	0.000691	0.00272	CcSEcCtD
Praziquantel—Asthenia—Ibandronate—osteoporosis	0.00069	0.00272	CcSEcCtD
Praziquantel—Nausea—Etidronic acid—osteoporosis	0.000688	0.00271	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000686	0.0027	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000686	0.0027	CcSEcCtD
Praziquantel—Diarrhoea—Estropipate—osteoporosis	0.000686	0.0027	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Risedronate—osteoporosis	0.000684	0.0027	CcSEcCtD
Praziquantel—Fatigue—Risedronate—osteoporosis	0.000683	0.00269	CcSEcCtD
Praziquantel—Pruritus—Ibandronate—osteoporosis	0.00068	0.00268	CcSEcCtD
Praziquantel—Diarrhoea—Alendronate—osteoporosis	0.000676	0.00266	CcSEcCtD
Praziquantel—Asthenia—Calcitriol—osteoporosis	0.000675	0.00266	CcSEcCtD
Praziquantel—Nervous system disorder—Zoledronate—osteoporosis	0.000675	0.00266	CcSEcCtD
Praziquantel—Immune system disorder—Estradiol—osteoporosis	0.000674	0.00266	CcSEcCtD
Praziquantel—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00067	0.00264	CcSEcCtD
Praziquantel—Somnolence—Pamidronate—osteoporosis	0.00067	0.00264	CcSEcCtD
Praziquantel—Skin disorder—Zoledronate—osteoporosis	0.000668	0.00263	CcSEcCtD
Praziquantel—Pruritus—Calcitriol—osteoporosis	0.000666	0.00262	CcSEcCtD
Praziquantel—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000665	0.00262	CcSEcCtD
Praziquantel—Diarrhoea—Raloxifene—osteoporosis	0.000664	0.00262	CcSEcCtD
Praziquantel—Dizziness—Estropipate—osteoporosis	0.000663	0.00261	CcSEcCtD
Praziquantel—Diarrhoea—Ibandronate—osteoporosis	0.000658	0.00259	CcSEcCtD
Praziquantel—Anorexia—Zoledronate—osteoporosis	0.000656	0.00258	CcSEcCtD
Praziquantel—Decreased appetite—Pamidronate—osteoporosis	0.000655	0.00258	CcSEcCtD
Praziquantel—Dizziness—Alendronate—osteoporosis	0.000653	0.00257	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00065	0.00256	CcSEcCtD
Praziquantel—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00065	0.00256	CcSEcCtD
Praziquantel—Fatigue—Pamidronate—osteoporosis	0.000649	0.00256	CcSEcCtD
Praziquantel—Gastrointestinal pain—Risedronate—osteoporosis	0.000648	0.00255	CcSEcCtD
Praziquantel—Urticaria—Ethinyl Estradiol—osteoporosis	0.000646	0.00254	CcSEcCtD
Praziquantel—Diarrhoea—Calcitriol—osteoporosis	0.000644	0.00254	CcSEcCtD
Praziquantel—Skin disorder—Conjugated Estrogens—osteoporosis	0.000643	0.00254	CcSEcCtD
Praziquantel—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000642	0.00253	CcSEcCtD
Praziquantel—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000642	0.00253	CcSEcCtD
Praziquantel—Dizziness—Raloxifene—osteoporosis	0.000642	0.00253	CcSEcCtD
Praziquantel—Vomiting—Estropipate—osteoporosis	0.000637	0.00251	CcSEcCtD
Praziquantel—Dizziness—Ibandronate—osteoporosis	0.000636	0.00251	CcSEcCtD
Praziquantel—Rash—Estropipate—osteoporosis	0.000632	0.00249	CcSEcCtD
Praziquantel—Dermatitis—Estropipate—osteoporosis	0.000632	0.00249	CcSEcCtD
Praziquantel—Anorexia—Conjugated Estrogens—osteoporosis	0.000631	0.00249	CcSEcCtD
Praziquantel—Urticaria—Risedronate—osteoporosis	0.000629	0.00248	CcSEcCtD
Praziquantel—Headache—Estropipate—osteoporosis	0.000628	0.00247	CcSEcCtD
Praziquantel—Vomiting—Alendronate—osteoporosis	0.000628	0.00247	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000627	0.00247	CcSEcCtD
Praziquantel—Abdominal pain—Risedronate—osteoporosis	0.000626	0.00247	CcSEcCtD
Praziquantel—Body temperature increased—Risedronate—osteoporosis	0.000626	0.00247	CcSEcCtD
Praziquantel—Rash—Alendronate—osteoporosis	0.000623	0.00245	CcSEcCtD
Praziquantel—Dermatitis—Alendronate—osteoporosis	0.000622	0.00245	CcSEcCtD
Praziquantel—Feeling abnormal—Pamidronate—osteoporosis	0.000621	0.00245	CcSEcCtD
Praziquantel—Headache—Alendronate—osteoporosis	0.000619	0.00244	CcSEcCtD
Praziquantel—Vomiting—Raloxifene—osteoporosis	0.000617	0.00243	CcSEcCtD
Praziquantel—Gastrointestinal pain—Pamidronate—osteoporosis	0.000616	0.00243	CcSEcCtD
Praziquantel—Rash—Raloxifene—osteoporosis	0.000612	0.00241	CcSEcCtD
Praziquantel—Dermatitis—Raloxifene—osteoporosis	0.000612	0.00241	CcSEcCtD
Praziquantel—Somnolence—Zoledronate—osteoporosis	0.000612	0.00241	CcSEcCtD
Praziquantel—Vomiting—Ibandronate—osteoporosis	0.000611	0.00241	CcSEcCtD
Praziquantel—Headache—Raloxifene—osteoporosis	0.000608	0.0024	CcSEcCtD
Praziquantel—Rash—Ibandronate—osteoporosis	0.000606	0.00239	CcSEcCtD
Praziquantel—Dermatitis—Ibandronate—osteoporosis	0.000606	0.00239	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000604	0.00238	CcSEcCtD
Praziquantel—Ill-defined disorder—Estradiol—osteoporosis	0.000603	0.00238	CcSEcCtD
Praziquantel—Headache—Ibandronate—osteoporosis	0.000602	0.00237	CcSEcCtD
Praziquantel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000599	0.00236	CcSEcCtD
Praziquantel—Vomiting—Calcitriol—osteoporosis	0.000598	0.00236	CcSEcCtD
Praziquantel—Decreased appetite—Zoledronate—osteoporosis	0.000598	0.00236	CcSEcCtD
Praziquantel—Nausea—Estropipate—osteoporosis	0.000596	0.00235	CcSEcCtD
Praziquantel—Abdominal pain—Pamidronate—osteoporosis	0.000595	0.00235	CcSEcCtD
Praziquantel—Body temperature increased—Pamidronate—osteoporosis	0.000595	0.00235	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000594	0.00234	CcSEcCtD
Praziquantel—Rash—Calcitriol—osteoporosis	0.000593	0.00234	CcSEcCtD
Praziquantel—Fatigue—Zoledronate—osteoporosis	0.000593	0.00234	CcSEcCtD
Praziquantel—Dermatitis—Calcitriol—osteoporosis	0.000593	0.00234	CcSEcCtD
Praziquantel—Headache—Calcitriol—osteoporosis	0.00059	0.00232	CcSEcCtD
Praziquantel—Somnolence—Conjugated Estrogens—osteoporosis	0.000589	0.00232	CcSEcCtD
Praziquantel—Nausea—Alendronate—osteoporosis	0.000587	0.00231	CcSEcCtD
Praziquantel—Malaise—Estradiol—osteoporosis	0.000586	0.00231	CcSEcCtD
Praziquantel—Hypersensitivity—Risedronate—osteoporosis	0.000584	0.0023	CcSEcCtD
Praziquantel—Vertigo—Estradiol—osteoporosis	0.000584	0.0023	CcSEcCtD
Praziquantel—Asthenia—Ethinyl Estradiol—osteoporosis	0.000583	0.0023	CcSEcCtD
Praziquantel—Nausea—Raloxifene—osteoporosis	0.000577	0.00227	CcSEcCtD
Praziquantel—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000576	0.00227	CcSEcCtD
Praziquantel—Pruritus—Ethinyl Estradiol—osteoporosis	0.000575	0.00227	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000572	0.00225	CcSEcCtD
Praziquantel—Fatigue—Conjugated Estrogens—osteoporosis	0.000571	0.00225	CcSEcCtD
Praziquantel—Nausea—Ibandronate—osteoporosis	0.000571	0.00225	CcSEcCtD
Praziquantel—Asthenia—Risedronate—osteoporosis	0.000568	0.00224	CcSEcCtD
Praziquantel—Feeling abnormal—Zoledronate—osteoporosis	0.000567	0.00223	CcSEcCtD
Praziquantel—Gastrointestinal pain—Zoledronate—osteoporosis	0.000563	0.00222	CcSEcCtD
Praziquantel—Pruritus—Risedronate—osteoporosis	0.000561	0.00221	CcSEcCtD
Praziquantel—Nausea—Calcitriol—osteoporosis	0.000559	0.0022	CcSEcCtD
Praziquantel—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000556	0.00219	CcSEcCtD
Praziquantel—Hypersensitivity—Pamidronate—osteoporosis	0.000555	0.00219	CcSEcCtD
Praziquantel—Myalgia—Estradiol—osteoporosis	0.000553	0.00218	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000549	0.00216	CcSEcCtD
Praziquantel—Urticaria—Zoledronate—osteoporosis	0.000547	0.00215	CcSEcCtD
Praziquantel—Discomfort—Estradiol—osteoporosis	0.000546	0.00215	CcSEcCtD
Praziquantel—Abdominal pain—Zoledronate—osteoporosis	0.000544	0.00214	CcSEcCtD
Praziquantel—Body temperature increased—Zoledronate—osteoporosis	0.000544	0.00214	CcSEcCtD
Praziquantel—Diarrhoea—Risedronate—osteoporosis	0.000542	0.00214	CcSEcCtD
Praziquantel—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000542	0.00213	CcSEcCtD
Praziquantel—Asthenia—Pamidronate—osteoporosis	0.00054	0.00213	CcSEcCtD
Praziquantel—Dizziness—Ethinyl Estradiol—osteoporosis	0.000537	0.00212	CcSEcCtD
Praziquantel—Pruritus—Pamidronate—osteoporosis	0.000533	0.0021	CcSEcCtD
Praziquantel—Urticaria—Conjugated Estrogens—osteoporosis	0.000526	0.00207	CcSEcCtD
Praziquantel—Dizziness—Risedronate—osteoporosis	0.000524	0.00206	CcSEcCtD
Praziquantel—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000524	0.00206	CcSEcCtD
Praziquantel—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000524	0.00206	CcSEcCtD
Praziquantel—Nervous system disorder—Estradiol—osteoporosis	0.00052	0.00205	CcSEcCtD
Praziquantel—Vomiting—Ethinyl Estradiol—osteoporosis	0.000517	0.00204	CcSEcCtD
Praziquantel—Diarrhoea—Pamidronate—osteoporosis	0.000515	0.00203	CcSEcCtD
Praziquantel—Skin disorder—Estradiol—osteoporosis	0.000515	0.00203	CcSEcCtD
Praziquantel—Rash—Ethinyl Estradiol—osteoporosis	0.000512	0.00202	CcSEcCtD
Praziquantel—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000512	0.00202	CcSEcCtD
Praziquantel—Headache—Ethinyl Estradiol—osteoporosis	0.000509	0.00201	CcSEcCtD
Praziquantel—Hypersensitivity—Zoledronate—osteoporosis	0.000507	0.002	CcSEcCtD
Praziquantel—Vomiting—Risedronate—osteoporosis	0.000504	0.00199	CcSEcCtD
Praziquantel—Rash—Risedronate—osteoporosis	0.0005	0.00197	CcSEcCtD
Praziquantel—Dermatitis—Risedronate—osteoporosis	0.000499	0.00197	CcSEcCtD
Praziquantel—Dizziness—Pamidronate—osteoporosis	0.000498	0.00196	CcSEcCtD
Praziquantel—Headache—Risedronate—osteoporosis	0.000496	0.00196	CcSEcCtD
Praziquantel—Asthenia—Zoledronate—osteoporosis	0.000494	0.00195	CcSEcCtD
Praziquantel—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000488	0.00192	CcSEcCtD
Praziquantel—Pruritus—Zoledronate—osteoporosis	0.000487	0.00192	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000483	0.0019	CcSEcCtD
Praziquantel—Nausea—Ethinyl Estradiol—osteoporosis	0.000483	0.0019	CcSEcCtD
Praziquantel—Vomiting—Pamidronate—osteoporosis	0.000479	0.00189	CcSEcCtD
Praziquantel—Asthenia—Conjugated Estrogens—osteoporosis	0.000475	0.00187	CcSEcCtD
Praziquantel—Rash—Pamidronate—osteoporosis	0.000475	0.00187	CcSEcCtD
Praziquantel—Dermatitis—Pamidronate—osteoporosis	0.000474	0.00187	CcSEcCtD
Praziquantel—Headache—Pamidronate—osteoporosis	0.000472	0.00186	CcSEcCtD
Praziquantel—Somnolence—Estradiol—osteoporosis	0.000471	0.00186	CcSEcCtD
Praziquantel—Diarrhoea—Zoledronate—osteoporosis	0.000471	0.00185	CcSEcCtD
Praziquantel—Nausea—Risedronate—osteoporosis	0.000471	0.00185	CcSEcCtD
Praziquantel—Pruritus—Conjugated Estrogens—osteoporosis	0.000469	0.00185	CcSEcCtD
Praziquantel—Decreased appetite—Estradiol—osteoporosis	0.000461	0.00182	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Estradiol—osteoporosis	0.000458	0.0018	CcSEcCtD
Praziquantel—Fatigue—Estradiol—osteoporosis	0.000457	0.0018	CcSEcCtD
Praziquantel—Dizziness—Zoledronate—osteoporosis	0.000455	0.00179	CcSEcCtD
Praziquantel—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000453	0.00179	CcSEcCtD
Praziquantel—Nausea—Pamidronate—osteoporosis	0.000447	0.00176	CcSEcCtD
Praziquantel—Dizziness—Conjugated Estrogens—osteoporosis	0.000438	0.00173	CcSEcCtD
Praziquantel—Vomiting—Zoledronate—osteoporosis	0.000437	0.00172	CcSEcCtD
Praziquantel—Feeling abnormal—Estradiol—osteoporosis	0.000437	0.00172	CcSEcCtD
Praziquantel—Rash—Zoledronate—osteoporosis	0.000434	0.00171	CcSEcCtD
Praziquantel—Gastrointestinal pain—Estradiol—osteoporosis	0.000434	0.00171	CcSEcCtD
Praziquantel—Dermatitis—Zoledronate—osteoporosis	0.000433	0.00171	CcSEcCtD
Praziquantel—Headache—Zoledronate—osteoporosis	0.000431	0.0017	CcSEcCtD
Praziquantel—Vomiting—Conjugated Estrogens—osteoporosis	0.000421	0.00166	CcSEcCtD
Praziquantel—Urticaria—Estradiol—osteoporosis	0.000421	0.00166	CcSEcCtD
Praziquantel—Abdominal pain—Estradiol—osteoporosis	0.000419	0.00165	CcSEcCtD
Praziquantel—Body temperature increased—Estradiol—osteoporosis	0.000419	0.00165	CcSEcCtD
Praziquantel—Rash—Conjugated Estrogens—osteoporosis	0.000418	0.00165	CcSEcCtD
Praziquantel—Dermatitis—Conjugated Estrogens—osteoporosis	0.000417	0.00164	CcSEcCtD
Praziquantel—Headache—Conjugated Estrogens—osteoporosis	0.000415	0.00164	CcSEcCtD
Praziquantel—Nausea—Zoledronate—osteoporosis	0.000409	0.00161	CcSEcCtD
Praziquantel—Nausea—Conjugated Estrogens—osteoporosis	0.000393	0.00155	CcSEcCtD
Praziquantel—Hypersensitivity—Estradiol—osteoporosis	0.000391	0.00154	CcSEcCtD
Praziquantel—Asthenia—Estradiol—osteoporosis	0.00038	0.0015	CcSEcCtD
Praziquantel—Pruritus—Estradiol—osteoporosis	0.000375	0.00148	CcSEcCtD
Praziquantel—Diarrhoea—Estradiol—osteoporosis	0.000363	0.00143	CcSEcCtD
Praziquantel—Dizziness—Estradiol—osteoporosis	0.000351	0.00138	CcSEcCtD
Praziquantel—Vomiting—Estradiol—osteoporosis	0.000337	0.00133	CcSEcCtD
Praziquantel—Rash—Estradiol—osteoporosis	0.000334	0.00132	CcSEcCtD
Praziquantel—Dermatitis—Estradiol—osteoporosis	0.000334	0.00132	CcSEcCtD
Praziquantel—Headache—Estradiol—osteoporosis	0.000332	0.00131	CcSEcCtD
Praziquantel—Nausea—Estradiol—osteoporosis	0.000315	0.00124	CcSEcCtD
Praziquantel—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	9.12e-05	0.0056	CbGpPWpGaD
Praziquantel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	9.09e-05	0.00559	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP27A1—osteoporosis	8.99e-05	0.00552	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	8.89e-05	0.00546	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP27A1—osteoporosis	8.86e-05	0.00545	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GPD2—osteoporosis	8.71e-05	0.00535	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PGLS—osteoporosis	8.71e-05	0.00535	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.48e-05	0.00521	CbGpPWpGaD
Praziquantel—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.36e-05	0.00514	CbGpPWpGaD
Praziquantel—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	8.17e-05	0.00502	CbGpPWpGaD
Praziquantel—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	7.99e-05	0.00491	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PNP—osteoporosis	7.97e-05	0.0049	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ATIC—osteoporosis	7.97e-05	0.0049	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	7.87e-05	0.00483	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.8e-05	0.00479	CbGpPWpGaD
Praziquantel—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.69e-05	0.00473	CbGpPWpGaD
Praziquantel—CYP3A7—Phase 1 - Functionalization of compounds—POMC—osteoporosis	7.39e-05	0.00454	CbGpPWpGaD
Praziquantel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	7.02e-05	0.00431	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	6.95e-05	0.00427	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.87e-05	0.00422	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	6.85e-05	0.00421	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CA2—osteoporosis	6.78e-05	0.00416	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—OXCT1—osteoporosis	6.78e-05	0.00416	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	6.6e-05	0.00406	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—MGLL—osteoporosis	6.6e-05	0.00406	CbGpPWpGaD
Praziquantel—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	6.59e-05	0.00405	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—CYP19A1—osteoporosis	6.53e-05	0.00401	CbGpPWpGaD
Praziquantel—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	6.52e-05	0.004	CbGpPWpGaD
Praziquantel—CYP3A7—Metapathway biotransformation—CYP19A1—osteoporosis	6.44e-05	0.00396	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	6.39e-05	0.00393	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.32e-05	0.00388	CbGpPWpGaD
Praziquantel—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	6.3e-05	0.00387	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	6.3e-05	0.00387	CbGpPWpGaD
Praziquantel—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	6.22e-05	0.00382	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—IDH2—osteoporosis	5.61e-05	0.00345	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	5.46e-05	0.00335	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	5.41e-05	0.00333	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.35e-05	0.00329	CbGpPWpGaD
Praziquantel—CYP3A5—Phase 1 - Functionalization of compounds—POMC—osteoporosis	5.34e-05	0.00328	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	5.34e-05	0.00328	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP27A1—osteoporosis	5.28e-05	0.00324	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ACP5—osteoporosis	5.14e-05	0.00315	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.1e-05	0.00313	CbGpPWpGaD
Praziquantel—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.09e-05	0.00313	CbGpPWpGaD
Praziquantel—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.03e-05	0.00309	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—TPI1—osteoporosis	4.77e-05	0.00293	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—CYP19A1—osteoporosis	4.72e-05	0.0029	CbGpPWpGaD
Praziquantel—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.69e-05	0.00288	CbGpPWpGaD
Praziquantel—CYP3A5—Metapathway biotransformation—CYP19A1—osteoporosis	4.66e-05	0.00286	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.65e-05	0.00285	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—P4HB—osteoporosis	4.49e-05	0.00276	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GAPDH—osteoporosis	4.41e-05	0.00271	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.4e-05	0.00271	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—RAP1A—osteoporosis	4.29e-05	0.00264	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.18e-05	0.00257	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.13e-05	0.00254	CbGpPWpGaD
Praziquantel—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.13e-05	0.00254	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.12e-05	0.00253	CbGpPWpGaD
Praziquantel—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.97e-05	0.00244	CbGpPWpGaD
Praziquantel—CYP3A7—Biological oxidations—POMC—osteoporosis	3.93e-05	0.00241	CbGpPWpGaD
Praziquantel—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.8e-05	0.00233	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PKM—osteoporosis	3.7e-05	0.00227	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—FDPS—osteoporosis	3.7e-05	0.00227	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	3.65e-05	0.00224	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	3.64e-05	0.00224	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.62e-05	0.00222	CbGpPWpGaD
Praziquantel—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	3.6e-05	0.00221	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GPD2—osteoporosis	3.51e-05	0.00216	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PGLS—osteoporosis	3.51e-05	0.00216	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ENO1—osteoporosis	3.47e-05	0.00213	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.43e-05	0.00211	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.42e-05	0.0021	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PSMA2—osteoporosis	3.42e-05	0.0021	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—PSMA5—osteoporosis	3.42e-05	0.0021	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	3.36e-05	0.00206	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.34e-05	0.00205	CbGpPWpGaD
Praziquantel—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	3.31e-05	0.00203	CbGpPWpGaD
Praziquantel—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.22e-05	0.00198	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PNP—osteoporosis	3.21e-05	0.00197	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ATIC—osteoporosis	3.21e-05	0.00197	CbGpPWpGaD
Praziquantel—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.06e-05	0.00188	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	2.84e-05	0.00175	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.84e-05	0.00174	CbGpPWpGaD
Praziquantel—CYP3A5—Biological oxidations—POMC—osteoporosis	2.84e-05	0.00174	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.83e-05	0.00174	CbGpPWpGaD
Praziquantel—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	2.8e-05	0.00172	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—CYP19A1—osteoporosis	2.77e-05	0.0017	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CA2—osteoporosis	2.73e-05	0.00168	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—OXCT1—osteoporosis	2.73e-05	0.00168	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—FDPS—osteoporosis	2.68e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PKM—osteoporosis	2.68e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.67e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.67e-05	0.00164	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—MGLL—osteoporosis	2.66e-05	0.00163	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.64e-05	0.00162	CbGpPWpGaD
Praziquantel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.64e-05	0.00162	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.6e-05	0.0016	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GPD2—osteoporosis	2.54e-05	0.00156	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PGLS—osteoporosis	2.54e-05	0.00156	CbGpPWpGaD
Praziquantel—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.48e-05	0.00153	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PNP—osteoporosis	2.32e-05	0.00143	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ATIC—osteoporosis	2.32e-05	0.00143	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.27e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—ADCY5—osteoporosis	2.27e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—IDH2—osteoporosis	2.26e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—GPX1—osteoporosis	2.26e-05	0.00139	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.19e-05	0.00135	CbGpPWpGaD
Praziquantel—CYP2C19—Biological oxidations—POMC—osteoporosis	2.19e-05	0.00135	CbGpPWpGaD
Praziquantel—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.16e-05	0.00133	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.00131	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—MTHFR—osteoporosis	2.08e-05	0.00128	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.08e-05	0.00128	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—FDPS—osteoporosis	2.07e-05	0.00127	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PKM—osteoporosis	2.07e-05	0.00127	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ACP5—osteoporosis	2.07e-05	0.00127	CbGpPWpGaD
Praziquantel—CYP2D6—Biological oxidations—POMC—osteoporosis	2.02e-05	0.00124	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—OXCT1—osteoporosis	1.97e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CA2—osteoporosis	1.97e-05	0.00121	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GPD2—osteoporosis	1.96e-05	0.0012	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PGLS—osteoporosis	1.96e-05	0.0012	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—TPI1—osteoporosis	1.92e-05	0.00118	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MGLL—osteoporosis	1.92e-05	0.00118	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PKM—osteoporosis	1.9e-05	0.00117	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—FDPS—osteoporosis	1.9e-05	0.00117	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—P4HB—osteoporosis	1.81e-05	0.00111	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PGLS—osteoporosis	1.8e-05	0.00111	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GPD2—osteoporosis	1.8e-05	0.00111	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ATIC—osteoporosis	1.79e-05	0.0011	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PNP—osteoporosis	1.79e-05	0.0011	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GAPDH—osteoporosis	1.77e-05	0.00109	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.77e-05	0.00109	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—RAP1A—osteoporosis	1.73e-05	0.00106	CbGpPWpGaD
Praziquantel—CYP1A2—Biological oxidations—POMC—osteoporosis	1.71e-05	0.00105	CbGpPWpGaD
Praziquantel—CYP3A43—Metabolism—POMC—osteoporosis	1.67e-05	0.00102	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PNP—osteoporosis	1.65e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ATIC—osteoporosis	1.65e-05	0.00101	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—IDH2—osteoporosis	1.63e-05	0.001	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PKM—osteoporosis	1.61e-05	0.00099	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—FDPS—osteoporosis	1.61e-05	0.00099	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP27A1—osteoporosis	1.54e-05	0.000944	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PGLS—osteoporosis	1.53e-05	0.000939	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GPD2—osteoporosis	1.53e-05	0.000939	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CA2—osteoporosis	1.53e-05	0.000937	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—OXCT1—osteoporosis	1.53e-05	0.000937	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ACP5—osteoporosis	1.5e-05	0.000918	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MGLL—osteoporosis	1.49e-05	0.000913	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—OXCT1—osteoporosis	1.4e-05	0.000862	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CA2—osteoporosis	1.4e-05	0.000862	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.4e-05	0.000861	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PNP—osteoporosis	1.4e-05	0.000859	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ATIC—osteoporosis	1.4e-05	0.000859	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ENO1—osteoporosis	1.4e-05	0.000858	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—TPI1—osteoporosis	1.39e-05	0.000854	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000846	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000846	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MGLL—osteoporosis	1.37e-05	0.00084	CbGpPWpGaD
Praziquantel—CYP3A4—Biological oxidations—POMC—osteoporosis	1.32e-05	0.00081	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—P4HB—osteoporosis	1.31e-05	0.000803	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GAPDH—osteoporosis	1.28e-05	0.000788	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—IDH2—osteoporosis	1.26e-05	0.000776	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—RAP1A—osteoporosis	1.25e-05	0.000768	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PKM—osteoporosis	1.24e-05	0.000764	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—FDPS—osteoporosis	1.24e-05	0.000764	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—OXCT1—osteoporosis	1.19e-05	0.00073	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CA2—osteoporosis	1.19e-05	0.00073	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.19e-05	0.00073	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PGLS—osteoporosis	1.18e-05	0.000725	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPD2—osteoporosis	1.18e-05	0.000725	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—IDH2—osteoporosis	1.16e-05	0.000714	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MGLL—osteoporosis	1.16e-05	0.000711	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ACP5—osteoporosis	1.16e-05	0.00071	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.14e-05	0.000701	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.000686	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.09e-05	0.000671	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.09e-05	0.000671	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ATIC—osteoporosis	1.08e-05	0.000663	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PNP—osteoporosis	1.08e-05	0.000663	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—TPI1—osteoporosis	1.07e-05	0.00066	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ACP5—osteoporosis	1.06e-05	0.000653	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—P4HB—osteoporosis	1.01e-05	0.000621	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ENO1—osteoporosis	1.01e-05	0.00062	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PSMA5—osteoporosis	9.95e-06	0.000611	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—PSMA2—osteoporosis	9.95e-06	0.000611	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GAPDH—osteoporosis	9.92e-06	0.000609	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—TPI1—osteoporosis	9.88e-06	0.000607	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—IDH2—osteoporosis	9.85e-06	0.000605	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—RAP1A—osteoporosis	9.66e-06	0.000593	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—P4HB—osteoporosis	9.29e-06	0.000571	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP27A1—osteoporosis	9.26e-06	0.000569	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—OXCT1—osteoporosis	9.17e-06	0.000563	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CA2—osteoporosis	9.17e-06	0.000563	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—ADCY5—osteoporosis	9.13e-06	0.000561	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GAPDH—osteoporosis	9.12e-06	0.00056	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—GPX1—osteoporosis	9.09e-06	0.000559	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ACP5—osteoporosis	9.01e-06	0.000553	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MGLL—osteoporosis	8.94e-06	0.000549	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.89e-06	0.000546	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—RAP1A—osteoporosis	8.88e-06	0.000546	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.42e-06	0.000517	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—MTHFR—osteoporosis	8.39e-06	0.000516	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—TPI1—osteoporosis	8.37e-06	0.000514	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—CYP19A1—osteoporosis	8.07e-06	0.000496	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—P4HB—osteoporosis	7.87e-06	0.000484	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ENO1—osteoporosis	7.81e-06	0.00048	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GAPDH—osteoporosis	7.73e-06	0.000475	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PSMA5—osteoporosis	7.69e-06	0.000473	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—PSMA2—osteoporosis	7.69e-06	0.000473	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—IDH2—osteoporosis	7.6e-06	0.000467	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—RAP1A—osteoporosis	7.53e-06	0.000462	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ENO1—osteoporosis	7.18e-06	0.000441	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP27A1—osteoporosis	7.15e-06	0.000439	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PSMA2—osteoporosis	7.08e-06	0.000435	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—PSMA5—osteoporosis	7.08e-06	0.000435	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ACP5—osteoporosis	6.95e-06	0.000427	CbGpPWpGaD
Praziquantel—CYP3A7—Metabolism—POMC—osteoporosis	6.71e-06	0.000412	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—ADCY5—osteoporosis	6.6e-06	0.000405	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—GPX1—osteoporosis	6.57e-06	0.000404	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.56e-06	0.000403	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—TPI1—osteoporosis	6.46e-06	0.000397	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—CYP19A1—osteoporosis	6.24e-06	0.000383	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ENO1—osteoporosis	6.08e-06	0.000374	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—P4HB—osteoporosis	6.08e-06	0.000373	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—MTHFR—osteoporosis	6.07e-06	0.000373	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PSMA2—osteoporosis	5.99e-06	0.000368	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—PSMA5—osteoporosis	5.99e-06	0.000368	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GAPDH—osteoporosis	5.96e-06	0.000366	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—RAP1A—osteoporosis	5.81e-06	0.000357	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—CYP19A1—osteoporosis	5.74e-06	0.000353	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—ADCY5—osteoporosis	5.1e-06	0.000313	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—GPX1—osteoporosis	5.08e-06	0.000312	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—CYP19A1—osteoporosis	4.86e-06	0.000299	CbGpPWpGaD
Praziquantel—CYP3A5—Metabolism—POMC—osteoporosis	4.85e-06	0.000298	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ENO1—osteoporosis	4.7e-06	0.000288	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—ADCY5—osteoporosis	4.69e-06	0.000288	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—MTHFR—osteoporosis	4.69e-06	0.000288	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—GPX1—osteoporosis	4.67e-06	0.000287	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PSMA2—osteoporosis	4.63e-06	0.000284	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—PSMA5—osteoporosis	4.63e-06	0.000284	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—MTHFR—osteoporosis	4.31e-06	0.000265	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—ADCY5—osteoporosis	3.97e-06	0.000244	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—GPX1—osteoporosis	3.96e-06	0.000243	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—CYP19A1—osteoporosis	3.75e-06	0.000231	CbGpPWpGaD
Praziquantel—CYP2C19—Metabolism—POMC—osteoporosis	3.75e-06	0.00023	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—MTHFR—osteoporosis	3.65e-06	0.000225	CbGpPWpGaD
Praziquantel—CYP2D6—Metabolism—POMC—osteoporosis	3.45e-06	0.000212	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—ADCY5—osteoporosis	3.07e-06	0.000188	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—GPX1—osteoporosis	3.06e-06	0.000188	CbGpPWpGaD
Praziquantel—CYP1A2—Metabolism—POMC—osteoporosis	2.92e-06	0.00018	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—MTHFR—osteoporosis	2.82e-06	0.000173	CbGpPWpGaD
Praziquantel—CYP3A4—Metabolism—POMC—osteoporosis	2.26e-06	0.000139	CbGpPWpGaD
